Patient Guide: A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06790121
Status: ACTIVE_NOT_RECRUITING
Condition: Dermatitis Atopic
Phase: PHASE2

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Encino, California
  • • Thousand Oaks, California
  • • Boca Raton, Florida
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis - Join Clinical Trial NCTNCT06790121

How to Join This Clinical Trial - NCTNCT06790121

Learn how to participate in this PHASE2 trial studying an investigational therapy for Dermatitis Atopic. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Dermatitis Atopic. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Dermatitis Atopic
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06790121 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Encino, California 91436 - United States

Status: Contact for availability

Clinical Research Site

Thousand Oaks, California 91320 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33486 - United States

Status: Contact for availability

Clinical Research Site

Coral Gables, Florida 33134 - United States

Status: Contact for availability

Clinical Research Site

New Albany, Indiana 47150 - United States

Status: Contact for availability

Clinical Research Site

Plainfield, Indiana 46168 - United States

Status: Contact for availability

Clinical Research Site

Covington, Louisiana 70433 - United States

Status: Contact for availability

Clinical Research Site

Saint Joseph, Missouri 64506 - United States

Status: Contact for availability

Clinical Research Site

Reno, Nevada 89509 - United States

Status: Contact for availability

Clinical Research Site

Fargo, North Dakota 58103 - United States

Status: Contact for availability

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Dermatitis Atopic:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships